Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Assistive Device Training in Multiple Sclerosis (ADT)

20. september 2016 opdateret af: Michelle H. Cameron, MD, PT, MCR, Portland VA Medical Center

Assistive Device Training for Functional Mobility and Connectivity in Multiple Sclerosis

The purpose of this study is to determine whether a training program in the use of ambulatory assistive devices (such as canes, walkers, etc) can reduce falls and increase functional mobility and neural connectivity in people with Multiple Sclerosis.

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

40 people with Multiple Sclerosis, who routinely use ambulatory assistive devices and have fallen at least once in the past year, will be randomized into two groups. One group will receive a 6-week training program in the use of their assistive device; the other group will be wait-listed, and may choose to receive the training after their participation in the study is completed. All participants will receive mobility assessments at baseline, 6-8 weeks later, and 3 months after that. All participants will record their falls on falls calendars. Participants in the training group will receive MRI scans to assess neural connectivity at baseline and after completion of the training program.

The purpose of the study is to determine whether participation in the training program reduces falls and increases functional mobility when compared to the wait-listed group, and also to determine whether any change in neural connectivity, as assessed by MRI scans, is seen in those who participate in the training.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

40

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

  • Forenede Stater
    • Oregon
      • Portland, Oregon, Forenede Stater, 97239
        • VA Portland Health Care System

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Multiple Sclerosis of any type,
  • self-reported history of at least 1 fall in the previous year,
  • able to walk at least 25 feet with or without an assistive device,
  • clinically stable Multiple Sclerosis (no relapse in 30 days prior to enrollment),
  • intermittent or constant unilateral or bilateral assistance required to walk,
  • right-handed, willingness to remain consistent with medication use and level of physical activity for the duration of the study.

Exclusion Criteria:

  • serious psychiatric or medical conditions that would preclude reliable participation in the study,
  • dementia (MMSE <24),
  • deafness,
  • blindness,
  • inability to follow directions in English,
  • significant upper extremity tremor or weakness,
  • more than 1 hour of assistive device training within the previous 3 years,
  • any exclusions to receiving MRI scans (implanted devices, anxiety, claustrophobia, body weight over 350 lbs).

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: Training group
Subjects randomized to this group will receive a 6 week Assistive Device Training program in the use of their assistive device. They will have mobility assessments taken at baseline, after the training program has been completed, and 3 months later. During this time, their falls will be recorded monthly using prospective falls calendars. Members of this group will also receive MRI scans at baseline and after the completion of the training program.
Adfærdsmæssigt: Assistive Device Training
Six-week training program on the proper use of the subject's assistive device (eg. cane, walker, etc).
Ingen indgriben: Wait-list control
Subjects in this group will participate in the same mobility assessments and completion of the falls calendars, but will receive no intervention during this time. These subjects will have the opportunity to receive the training sessions when all assessment visits have been completed. These subjects will not receive MRI scans.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change from Baseline in Functional Mobility at Completion of Training and the Following Three Months
Tidsramme: At baseline, 1 week after completion of training, 3 months later
Timed Up and Go test, Timed 25-Foot Walk, 2 minute timed walk), Multiple Sclerosis Walking Scale-12
At baseline, 1 week after completion of training, 3 months later
Change from Baseline in Falls at Completion of Training and the Following Three Months
Tidsramme: First week of training, last week of training, 3 months later
Change in rate of falls between time frames
First week of training, last week of training, 3 months later
Change from Baseline in Functional Neural Connectivity (fMRI) at Completion of Training
Tidsramme: At baseline, 1 week after completion of training
Resting-state (task free) functional Magnetic Resonance Imaging (fcMRI)
At baseline, 1 week after completion of training

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change from Baseline in Satisfaction with Assistive Device at Completion of Training and the Following Three Months
Tidsramme: At baseline, 1 week after completion of training, 3 months later
Quebec User Evaluation of Satisfaction with Assistive Technologies
At baseline, 1 week after completion of training, 3 months later
Change from Baseline in Balance Confidence at Completion of Training and the Following Three Months
Tidsramme: At baseline, 1 week after completion of training, 3 months later
Activities-specific Balance Confidence Questionnaire
At baseline, 1 week after completion of training, 3 months later
Change from Baseline in Multiple Sclerosis Impact at Completion of Training and the Following Three Months
Tidsramme: At baseline, 1 week after completion of training, 3 months later
Multiple Sclerosis Impact Scale-29
At baseline, 1 week after completion of training, 3 months later
Change from Baseline in Physical Activity at Completion of Training and the Following Three Months
Tidsramme: At baseline, 1 week after completion of training, 3 months later
International Physical Activity Questionnaire
At baseline, 1 week after completion of training, 3 months later

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Portland VA Medical Center

Samarbejdspartnere

Oregon Health and Science University

Efterforskere

  • Ledende efterforsker: Michelle H. Cameron, MD, PT MCR, Portland VA Medical Center

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. juli 2015

Primær færdiggørelse (Faktiske)

1. september 2016

Studieafslutning (Faktiske)

1. september 2016

Datoer for studieregistrering

Først indsendt

27. marts 2015

Først indsendt, der opfyldte QC-kriterier

2. april 2015

Først opslået (Skøn)

3. april 2015

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

21. september 2016

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

20. september 2016

Sidst verificeret

1. april 2016

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • 3559

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Multipel sclerose

  • City of Hope Medical Center
    National Cancer Institute (NCI)
    Aktiv, ikke rekrutterende
    Brentuximab Vedotin og Nivolumab til behandling af patienter med klassisk Hodgkin-lymfom i tidlige stadier
    Klassisk Hodgkin lymfom | Lymfocytrigt klassisk Hodgkin-lymfom | Ann Arbor Stage IB Hodgkin lymfom | Ann Arbor Stage II Hodgkin lymfom | Ann Arbor Stage IIA Hodgkin lymfom | Ann Arbor Stage IIB Hodgkin lymfom | Ann Arbor Stage I Hodgkin lymfom | Ann Arbor Stage I Mixed Cellularity Klassisk Hodgkin-lymfom og andre forhold
    Forenede Stater

Kliniske forsøg med Assistive Device Training

Søg i lignende forsøg

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

CROs by country

CROs in Uzbekistan

Betingelser

Sjældne sygdomme

Narkotikainterventioner

Kosttilskud

Sponsor / samarbejdspartnere

Placeringer

3
Abonner